We are looking to talk to women in Ireland who have used GLP-1-RA medications (e.g. Ozempic, Mounjaro or Wegovy) for obesity management about their subsequent pregnancy and/or postpartum journeys following medication use. 

To take part, you must:

  • Be aged 18+
  • Living in the Republic of Ireland
  • Prescribed a GLP-1-RA medication (such as Ozempic, Mounjaro or Wegovy) for weight management 
  • Currently pregnant or up to two years' postpartum.

Participation will involve:

  • A short online questionnaire
  • An individual online interview via Microsoft Teams

Little is known about this topic, so your input could help inform future care and support for women from preconception to postpartum. If you are interested in taking part in this study, please get in touch at: deirbhlefergus25@rcsi.com

As recruitment is ongoing, please feel free to share study information with any relevant networks!

Participant information sheet: https://docs.google.com/document/d/1JBRFBvMHQxZxeZElU1Dv9IyTRXk4gvRK4V1bI2mMduE/edit?usp=sharing